Dermorphin is a naturally occurring heptapeptide (7-amino-acid structure: Tyr-D-Ala-Phe-Gly-Tyr-Pro-Ser-NH₂) first isolated from the skin secretions of South American tree frogs (Phyllomedusa bicolor). It is a potent opioid receptor agonist—specifically targeting μ-opioid receptors (MORs)—with biological activity far exceeding that of morphine (50–400 times more potent in pain relief). How It Works?
Selective μ-opioid receptor (MOR) activation
Pain signaling inhibition
Euphoria & sedation induction
Peripheral effects
Potency amplification
Key Features & Benefits
1.Core Features
Potent μ-opioid receptor (MOR) selectivity: Binds exclusively to MORs with 50–400x higher affinity than morphine, ensuring targeted action.
Natural peptide origin: Isolated from Phyllomedusa bicolor frog skin (defensive secretion) with a 7-amino-acid structure; synthetic analogs enhance stability.
Long-acting & enzyme-resistant: Contains D-amino acid, resisting degradation by peptidases—longer half-life (2–4 hours) vs. morphine.
Ultra-low effective dose: Active in microgram ranges, far more potent than conventional opioid analgesics.
2.Research-Oriented Benefits
Powerful analgesic potential: Blocks pain signaling more effectively than morphine, valuable for studying severe pain pathways in preclinical research.
Opioid receptor biology tool: Enables precise investigation of MOR function, aiding development of safer analgesics (e.g., non-addictive opioids).
Peripheral activity insights: Helps research gastrointestinal motility regulation and smooth muscle physiology via peripheral MOR activation.
Applications
1. Preclinical & Scientific Research (Primary Use)
Opioid Receptor Biology Studies: Used to investigate μ-opioid receptor (MOR) function, signaling pathways, and ligand-receptor interactions—providing insights for developing safer analgesics (e.g., non-addictive opioids).
Pain Pathway Research: Serves as a tool to model severe pain in animal studies, testing the efficacy of novel pain management therapies due to its ultra-potent analgesic activity.
Pharmacology & Toxicology Research: Used to study opioid metabolism, tolerance, dependence, and overdose mechanisms (e.g., respiratory depression pathways) to inform drug safety protocols.
Peripheral Physiology Studies: Investigates the role of MORs in gastrointestinal motility, smooth muscle function, and peripheral pain signaling.
2. No Approved Therapeutic or Commercial Applications
Not for Clinical Use: Despite potent analgesic properties, its high abuse potential, severe toxicity (respiratory depression, addiction), and lack of safety profiles have prevented FDA/EMA approval for pain management or other medical purposes.
Illegal Recreational Use: Strictly prohibited globally—classified as a controlled substance (e.g., Schedule I in the U.S.) due to intense euphoric effects and overdose risks.
